RohamTZamanianMD
Pulmonology • Stanford, CACritical Care Medicine, Pleural Disease
Assistant Professor, Medicine - Pulmonary & Critical Care Medicine, Stanford University Medical Center
Dr. Zamanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2002 - 2005
University of California (Irvine)Residency, Internal Medicine, 1999 - 2002
University of California, Irvine, School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2001 - 2025
American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Insulin Resistance in Pulmonary Arterial Hypertension Start of enrollment: 2008 Sep 01
- Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH) Start of enrollment: 2011 Jun 24
- A 48-week Study of the Effect of Dual Therapy (Inhaled Treprostinil and Tadafafil) Versus Monotherapy (Tadalafil). Start of enrollment: 2010 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- Comparison of the Prognostic Value of Right Atrial Echocardiographic Parameters in Pulmonary Arterial Hypertension.Danny Mohama, Pitchaya Worapongsatitaya, Bettia Celestin, Felipe Kazmirczak, Shadi P Bagherzadeh
The Journal of Heart and Lung Transplantation. 2025-03-20 - Medication Non-Adherence in Patients with Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry (PHAR).Eric W Robbins, Kaitlin Bradley, David B Badesch, Charles Burger, Amy M Chybowski
Annals of the American Thoracic Society. 2025-02-18 - Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center.Cyrus A Kholdani, Justin H Lee, Kai E Swenson, Juliana Liu, Andrew Hsi
Pulmonary Circulation. 2025-01-01
Authored Content
- Pulmonary Vascular Fellowship Training to Promote Excellence in PH Clinical Care: The Stanford PerspectiveSeptember 2020
Press Mentions
Tiakis Biotech AG Receives Positive Scientific Advice from the U.S. FDA for Planned Phase II Trial of TiprelestatJanuary 8th, 2025
Hemodynamic Trajectories and Outcomes in Patients with Pulmonary Arterial HypertensionDecember 6th, 2020
Inhaled Nitric Oxide Explored for COVID-19 OxygenationMay 13th, 2020- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
